Migraine Excellence Hub

This AAEM26 session reviewed recent evidence challenging traditional approaches to common orthopedic injuries.

This AAEM26 session reviewed recent evidence challenging traditional approaches to common orthopedic injuries.

This AAEM26 session reviewed recent evidence challenging traditional approaches to common orthopedic injuries.

This AAEM26 session reviewed recent evidence challenging traditional approaches to common orthopedic injuries.

Post hoc subgroup analysis of interim phase 3 data shows weight loss with atogepant in migraine and overweight or obesity.

Post hoc subgroup analysis of interim phase 3 data shows weight loss with atogepant in migraine and overweight or obesity.

Post hoc subgroup analysis of interim phase 3 data shows weight loss with atogepant in migraine and overweight or obesity.

Post hoc subgroup analysis of interim phase 3 data shows weight loss with atogepant in migraine and overweight or obesity.

Physicians managing chronic migraine may be interested in new comparative patient-reported data from the FORWARD study, which evaluated treatment satisfaction with onabotulinumtoxinA versus topiramate. In...

Physicians managing chronic migraine may be interested in new comparative patient-reported data from the FORWARD study, which evaluated treatment satisfaction with onabotulinumtoxinA versus topiramate. In...